Chemotherapy-free ‘cancer vaccine’ moves from mice to human trials at Stanford
Table of Contents
A recent Stanford cancer study that cured 97 percent of mice from tumors has now moved on to soliciting human volunteers for a new cutting-edge medical trial. The trial is part of a gathering wave of research into immunotherapy, a type of treatment that fights cancer by using the body’s immune system to attack tumors.
Source: sfgate.com
